During the past decade, CTI Clinical Research Center conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 30 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 27 clinical trials were completed. i.e. 84.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CTI Clinical Research Center" #1 sponsor was "Pfizer" with 11 trials, followed by "Allergan" with 5 trials sponsored, "Apnimed" with 4 trials sponsored, "Idorsia Pharmaceuticals Ltd." with 4 trials sponsored and "Satsuma Pharmaceuticals, Inc." with 4 trials sponsored. Other sponsors include 24 different institutions and companies that sponsored additional 27 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CTI Clinical Research Center" #1 collaborator was "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator, "Athenex, Inc." with 1 trials as a collaborator, "CTI Clinical Trial and Consulting Services" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Purdue Pharma LP" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "CTI Clinical Research Center" are "Migraine" (7 trials), "Obstructive Sleep Apnea" (7 trials), "Migraine, With or Without Aura" (5 trials), "Insomnia Disorder" (3 trials) and "Migraine With Aura" (3 trials). Many other conditions were trialed in "CTI Clinical Research Center" in a lesser frequency.

Most popular intervention types in "CTI Clinical Research Center" are "Drug" (45 trials), "Biological" (11 trials), "Other" (4 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Dihydroergotamine" (3 trials), "Placebo-matching Ubrogepant" (3 trials), "Ubrogepant" (3 trials) and "AD109" (2 trials). Other intervention names were less common.

The vast majority of trials in "CTI Clinical Research Center" are 56 trials for "All" genders.

Currently, there are NaN active trials in "CTI Clinical Research Center". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 41 completed trials in CTI Clinical Research Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in CTI Clinical Research Center, 6 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".